Doculara, L.; Evans, K.; Gooding, J.J.; Bayat, N.; Lock, R.B.
Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia. Cancers 2024, 16, 3990.
https://doi.org/10.3390/cancers16233990
AMA Style
Doculara L, Evans K, Gooding JJ, Bayat N, Lock RB.
Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia. Cancers. 2024; 16(23):3990.
https://doi.org/10.3390/cancers16233990
Chicago/Turabian Style
Doculara, Louise, Kathryn Evans, J. Justin Gooding, Narges Bayat, and Richard B. Lock.
2024. "Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia" Cancers 16, no. 23: 3990.
https://doi.org/10.3390/cancers16233990
APA Style
Doculara, L., Evans, K., Gooding, J. J., Bayat, N., & Lock, R. B.
(2024). Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia. Cancers, 16(23), 3990.
https://doi.org/10.3390/cancers16233990